Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period

European Journal of Clinical Pharmacology

Volumn 67, Issue 8, 2011, Pages 803-813

  Zhang, Xiaoqing ^a,b   Wang, Zhaowen ^a   Fan, Junwei ^a   Liu, Gaolin ^a   Peng, Zhihai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gene polymorphism; Interleukin 10; Liver transplantation; Tacrolimus

Indexed keywords

INTERLEUKIN 10; TACROLIMUS;

ABCB1 GENE; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHINESE; CONTROLLED STUDY; CYP3A5 GENE; CYTOKINE PRODUCTION; DNA POLYMORPHISM; DNA SEQUENCE; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; HUMAN; INTERLEUKIN 10 GENE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATOR GENE;

ADULT; CHINA; CYTOCHROME P-450 CYP3A; DRUG MONITORING; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TACROLIMUS; TISSUE DONORS; YOUNG ADULT;

EID: 79960946905     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-0993-8     Document Type: Article

References (34)

1. Goto M, Masuda S, Kiuchi T, Ogura Y, Oike F, Okuda M, Tanaka K, Inui K (2004) CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation. Pharmacogenetics 14:471
2. Wei-lin W, Jing J, Shu-sen Z, Li-hua W, Ting-bo L, Song-feng Y, Sheng Y (2006) Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients. Liver Transplant 12:775
3. Uesugi M, Masuda S, Katsura T, Oike F, Takada Y, Inui K (2006) Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients. Pharmacogenet Genomics 16:119
4. Yu S, Wu L, Jin J, Yan S, Jiang G, Xie H, Zheng S (2006) Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation. Transplantation 81:46-51 (Pubitemid 43122147)
5. Staatz CE, Goodman LK, Tett SE (2010) Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: part I. Clin Pharmacokinet 49:141-175
6. Zhang X, Liu Z, Zheng JM, Tang Z, Chen JS, Li LS (2005) Influence of CYP3A5 and MDRl polymorphisms on tacrolimus concentration in the early stage after renal transplantation. Clin Transplant 19:638-643 (Pubitemid 41341696)
7. Wang WL, Jin J, Zheng SS, Wu LH, Liang TB, Yu SF, Yan S (2006) Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients. Liver Transplant 12:775-780
8. Wang J, Zeevi A, McCurry K, Schuetz E, Zheng H, Iacono A, McDade K, Zaldonis D, Webber S, Watanabe RM, Burckart GJ (2006) Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 non-expressors. Transpl Immunol 15:235-240 (Pubitemid 43129392)
9. Gorski JC, Hall SD, Becker P, Affrime MB, Cutler DL, Haehner-Daniels B (2000) In vivo effects of interleukin-10 on human cytochrome P450 activity. Clin Pharmacol Ther 67:32-43
10. Li D, Zhu JY, Gao J, Wang X, Lou YQ, Zhang GL (2007) Polymorphisms of tumour necrosis factor-a, interleukin-10, cytochrome P450 3A5 and ABCB1 in Chinese liver transplant patients treated with immunosuppressant tacrolimus. Clin Chim Acta 383:133-139 (Pubitemid 47016461)
11. Haufroid V, Wallemacq P, VanKerckhove V, Elens L, De Meyer M, Eddour DC, Malaise J, Lison D, Mourad M (2006) CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. Am J Transplant 6:2706
12. Mourad M, Mourad G, Wallemacq P, Garrigue V, Van Bellingen C, Van Kerckhove V, De Meyer M, Malaise J, Eddour DC, Lison D, Squifflet JP, Haufroid V (2005) Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1polymorphisms and steroids. Transplantation 80:977
13. Anglicheau D, Verstuyft C, Laurent-Puig P, Becquemont L, Schlageter MH, Cassinat B (2003) Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients. J Am Soc Nephrol 14:1889-1896 (Pubitemid 36750485)
14. Zheng H, Webber S, Zeevi A, Schuetz E, Zhang J, Bowman P (2003) Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. Am J Transplant 3:477-483 (Pubitemid 36560101)
15. Saraiva M, O"Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170-181
16. Kabay B, Kocaefe C, Baykal A, Ozden H, Baycu C, Oner Z, Ozgüç M, Sayek I (2007) Interleukin-10 gene transfer: prevention of multiple organ injury in a murine cecal ligation and puncture model of sepsis. World J Surg 31:105-115 (Pubitemid 46089551)
17. Lan L, Chen Y, Sun C, Sun Q, Hu J, Li D (2008) Transplantation of bone marrow-derived hepatocyte stem cells transduced with adenovirus-mediated IL-10 gene reverses liver fibrosis in rats. Transpl Int 21(6):581-592 (Pubitemid 351600067)
18. Döll S, Schrickx JA, Dänicke S, Fink-Gremmels J (2009) Interactions of deoxynivalenol and lipopolysaccharides on cytokine excretion and mRNA expression in porcine hepatocytes and Kupffer cell enriched hepatocyte cultures. Toxicol Lett 190:96-105
19. Chen YX, Huang YH, Chen ZX, Zheng WD, Wang XZ (2008) Construction of eukaryotic expression plasmid containing rat interleukin-10 gene and its expression in BRL cells in vitro. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 24:332-334
20. Warlé MC, Metselaar HJ, Hop WC, Tilanus HW (2005) Cytokine gene polymorphisms and acute liver graft rejection: a metaanalysis. Liver Transpl 11:19-26 (Pubitemid 40124438)
21. Girnita DM, Burckart G, Zeevi A (2008) Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantation. Curr Opin Immunol 20:614-625
22. Warlé MC, Farhan A, Metselaar HJ, Hop WC, Perrey C, Zondervan PE, Kap M, de Rave S, Kwekkeboom J, Ijzermans JN, Tilanus HW, Pravica V, Hutchinson IV, Bouma GJ (2002) Cytokine gene polymorphisms and acute human liver graft rejection. Liver Transpl 8:603-611 (Pubitemid 34752708)
23. Wang J (2009) CYP3Apolymorphisms and immunosuppressive drugs in solid-organ transplantation. Expert Rev Mol Diagn 9:383-390
24. Lee CM, Pohl J, Morgan ET (2009) Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures. Drug Metab Dispos 37:865-872
25. Liptrott NJ, Penny M, Bray PG, Sathish J, Khoo SH, Back DJ, Owen A (2009) The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Br J Pharmacol 156:497-508
26. Bertilsson PM, Olsson P, Magnusson KE (2001) Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells. J Pharm Sci 90:638-646 (Pubitemid 32378385)
27. Lodewijk L, Mall A, Spearman CW, Kahn D (2009) Effect of liver regeneration on the pharmacokinetics of immunosuppressive drugs. Transplant Proc 41:379-381
28. Haas CE, Kaufman DC, Jones CE, Burstein AH, Reiss W (2003) Cytochrome P450 3A4 activity after surgical stress. Crit Care Med 31:1338-1346 (Pubitemid 36583841)
29. Iñiguez M, Dotor J, Feijoo E, Goñi S, Prieto J, Berasain C, Avila MA (2008) Novel pharmacologic strategies to protect the liver from ischemia-reperfusion injury. Recent Pat Cardiovasc Drug Discov 3:9-18 (Pubitemid 351211022)
30. Zhu J, Wang S, Bie P, Li X, Zhang Y, Xiong Y, Wang H, Ma Z, Li K, Dong J (2007) Apoptosis and regeneration of sinusoidal endothelial cells after extended cold preservation and transplantation of rat liver. Transplantation 84:1483-1491 (Pubitemid 350294724)
31. Favre C, Monti JA, Scapini C, Pellegrino J, Carnovale CE, Carrillo MC (1998) Putrescine decreases cytochrome P450 3A4 levels during liver regeneration in the rat. J Hepatol 28:700-708 (Pubitemid 28168009)
32. Dinant S, Veteläinen RL, Florquin S, van Vliet AK, van Gulik TM (2007) IL-10 attenuates hepatic I/R injury and promotes hepatocyte proliferation. J Surg Res 141:176-182 (Pubitemid 47042047)
33. Lan L, Chen YW, Sun C, Liu BW, Sun QL, Li DG (2009) Effect of interleukin 10 gene-modified bone marrow-derived liver stem cells transplantation on hepatic inflammatory response and liver regeneration in hepatic fibrosis rats. Zhonghua Gan Zang Bing Za Zhi 17:915-920
34. Golling M, Sadeghi M, Zipperle S, Fonouni H, Golriz M, Mehrabi A (2009) In vitro cytokine responses in liver transplant recipients treated with cyclosporine A and tacrolimus. Clin Transplant 23 (Suppl 21):83-91